1. BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer

   • Estelle Jamard
   • Bertrand Volard
   • Sophie Krieger

   Short Communication 25 October 2016 Pages: 167 - 171

   

2. Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores

   • D. G. Evans
   • E. R. Woodward
   • F. Lalloo

   Original Article Open access 31 October 2016 Pages: 173 - 179

   

3. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe

   • Natalia Bogdanova
   • Katja Pfeifer
   • Thilo Dörk

   Short Communication 10 November 2016 Pages: 181 - 186

   

4. Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer

   • Martin P. Nilsson
   • Christof Winter
   • Niklas Loman

   Original Article Open access 24 January 2017 Pages: 187 - 193

5. Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing

   • Anna Rohlin
   • Eva Rambech
   • Margareta Nordling

   Original Article Open access 30 September 2016 Pages: 195 - 203

6. Pain evaluation during gynaecological surveillance in women with Lynch syndrome

   • Jorien Helder-Woolderink
   • Geertruida de Bock
   • Marian Mourits

   Original Article Open access 27 October 2016 Pages: 205 - 210

   

7. Attenuated polyposis of the large bowel: a morphologic and molecular approach

   • Maurizio Ponz de Leon
   • Monica Pedroni
   • Luca Reggiani Bonetti

   Original Article 25 October 2016 Pages: 211 - 220

   

8. Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome

   • Eva Wielders
   • Elly Delzenne-Goette
   • Hein te Riele

   Original Article 21 November 2016 Pages: 221 - 229

   

9. Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency

   • Lior H. Katz
   • Shailesh Advani
   • Susan K. Peterson

   Original Article 10 November 2016 Pages: 231 - 237

10. Colonoscopy in Lynch syndrome: the need for a new quality score

    • Jurjen J. Boonstra
    • Wouter H. de Vos tot Nederveen Cappel
    • Hans F. A. Vasen

    Letter to the Editor 09 November 2016 Pages: 239 - 241

11. TP53 and CDKN1A mutation analysis in families with Li–Fraumeni and Li–Fraumeni like syndromes

    • Raissa Coelho Andrade
    • Anna Claudia Evangelista dos Santos
    • Fernando Regla Vargas

    Original Article 06 October 2016 Pages: 243 - 248

    

12. Cystic parathyroid glands in MEN1: A rare entity?

    • Tiziana Cavalli
    • Francesco Giudici
    • Francesco Tonelli

    Original Article 20 October 2016 Pages: 249 - 256

    

13. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway

    • Trine Levin
    • Lovise Mæhle

    Original Article Open access 01 November 2016 Pages: 257 - 265

    

14. A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro)

    • Rita Vale Rodrigues
    • Filipa Santos
    • António Dias Pereira

    Short Communication 22 October 2016 Pages: 267 - 270

    

15. Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands

    • Charlotte J. Dommering
    • Lidewij Henneman
    • Hanne Meijers-Heijboer

    Original Article Open access 08 November 2016 Pages: 271 - 277

    

16. Four generations of SDHB-related disease: complexities in management

    • U. Srirangalingam
    • M. LeCain
    • K. Metcalfe

    Original Article Open access 28 November 2016 Pages: 279 - 282

    

17. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients

    • Kristin L. Long
    • Carol Etzel
    • Elizabeth G. Grubbs

    Original Article 18 November 2016 Pages: 283 - 289

    

18. DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations

    • Eduardo J. Bardón-Cancho
    • Ana Haro-Díaz
    • Carmen Garrido-Colino

    Short Communication 09 November 2016 Pages: 291 - 294

    

19. Recurrent TP53 missense mutation in cancer patients of Arab descent

    • Aviad Zick
    • Luna Kadouri
    • Tamar Peretz

    Original Article 19 November 2016 Pages: 295 - 301

    

20. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor

    • Caroline Goehringer
    • Christian Sutter
    • Ute Moog

    Original Article 12 November 2016 Pages: 303 - 309